🇺🇸 FDA
Patent

US 6028207

Bone resorption inhibition/osteogenesis promotion compound

expired A61PA61P19/08A61P19/10

Quick answer

US patent 6028207 (Bone resorption inhibition/osteogenesis promotion compound) held by Institute of Pharmacology, West China University of Medical Sciences expires Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Institute of Pharmacology, West China University of Medical Sciences
Grant date
Tue Feb 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P19/08, A61P19/10, A61P3/02, A61P43/00